REDUCING PROPERTY OF SOME SLOW-ACTING ANTIRHEUMATIC DRUGS
- 1 January 1984
- journal article
- research article
- Vol. 11 (5) , 605-609
Abstract
Many slow acting antirheumatic drugs and several other drugs without antirheumatic activity possess a potential thiol function, i.e., a free SH group or one that is generated by hydrolysis. Since drugs with effective SH activity may react with intracellular disulfides, their reducing properties were evaluated by measuring their redox potential and their ability to react with glutathione, the most prevalent intracellular thiol and dithiobis (nitrobenzoic acid), a specific reactant for thiols. Drugs containing aromatic thiols are poor reducers and are generally devoid of antirheumatic activity. Antirheumatic drugs, such as D-penicillamine, levamisole, gold salts, thiopronine and captopril, are potential aliphatic thiols with strong reducing properties. These different antirheumatic drugs may therefore operate by a common mechanism through an altered cellular redox equilibrium and sulfide-disulfide exchanges.This publication has 2 references indexed in Scilit:
- Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1982
- Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.Annals of the Rheumatic Diseases, 1980